Product Information
ALYACEN 1-35 28 TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2063 per EA under NDC 68462039429. Its NADAC has been published 657 times since Nov 28, 2013.
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462039429
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA091634On Market Since
1/19/2012
Price Statistics
The NADAC for ALYACEN 1-35 28 TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 61.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2063 per EA |
|---|---|
| All-time high | $0.5877 (Feb 12, 2014) |
| All-time low | $0.1935 (May 22, 2024) |
| 52-week high | $0.2458 |
| 52-week low | $0.1981 |
| Median price | $0.3958 |
| Average price | $0.3791 |
| Largest weekly change | +39.2% (Jun 19, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ALYACEN 1-35 28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALYACEN 1-35 28 TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2063 per EA (NDC 68462039429), effective Jun 24, 2026.
How has the price of ALYACEN 1-35 28 TABLET changed over time?
Over the history we have for it, the NADAC for ALYACEN 1-35 28 TABLET has declined 61.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALYACEN 1-35 28 TABLET?
Since Nov 28, 2013, the NADAC for ALYACEN 1-35 28 TABLET has ranged from a low of $0.1935 (May 22, 2024) to a high of $0.5877 (Feb 12, 2014), with a median of $0.3958 per EA.
Are there cheaper alternatives to ALYACEN 1-35 28 TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as ALYACEN 1-35 28 TABLET, but none are currently priced below it.
Who manufactures ALYACEN 1-35 28 TABLET?
ALYACEN 1-35 28 TABLET (NDC 68462039429) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification